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ABSTRACT
Introduction: Emergency calls to ambulance services
are frequent for older people who have fallen, but
ambulance crews often leave patients at the scene
without ongoing care. Evidence shows that when left at
home with no further support older people often
experience subsequent falls which result in injury and
emergency-department attendances. SAFER 2 is an
evaluation of a new clinical protocol which allows
paramedics to assess and refer older people who have
fallen, and do not need hospital care, to community-
based falls services. In this protocol paper, we report
methods and progress during trial implementation.
SAFER 2 is recruiting patients through three ambulance
services. A successful trial will provide robust evidence
about the value of this new model of care, and enable
ambulance services to use resources efficiently.
Design: Pragmatic cluster randomised trial.
Methods and analysis: We randomly allocated 25
participating ambulance stations (clusters) in three
services to intervention or control group. Intervention
paramedics received training and clinical protocols for
assessing and referring older people who have fallen to
community-based falls services when appropriate,
while control paramedics deliver care as usual. Patients
are eligible for the trial if they are aged 65 or over;
resident in a participating falls service catchment area;
and attended by a trial paramedic following an
emergency call coded as a fall without priority
symptoms. The principal outcome is the rate of further
emergency contacts (or death), for any cause and for
falls. Secondary outcomes include further falls, health-
related quality of life, ‘fear of falling’, patient
satisfaction reported by participants through postal
questionnaires at 1 and 6 months, and quality and
ARTICLE SUMMARY
Article focus
▪ Despite recent focus on the benefits of introdu-
cing new falls pathways for older adults within
the NHS, no studies have evaluated their effect-
iveness within a pre-hospital setting.
▪ This article is a protocol of SAFER 2, a cluster
randomised trial evaluating the safety, clinical
and cost effectiveness of a protocol for parame-
dics, enabling them to assess and refer older
adults to a community based falls service.
▪ The focus of this article is to detail how the
SAFER 2 intervention will be evaluated: what
design and methods are being used and what
outcomes are included.
Key messages
▪ The key aim of this article is to detail the design
and methods of the SAFER 2 trial, which mea-
sures the safety, clinical and cost effectiveness
of a new protocol for paramedics enabling them
to assess and refer older adults to a community
based falls service.
▪ This article provides an understanding of the
groundwork required to set up and implement a
trial of a complex intervention within the pre-
hospital setting.
Strengths and limitations of this study
▪ SAFER 2 followed the MRC Framework for devel-
oping and evaluating complex interventions.
▪ Using a cluster randomised trial design will
provide robust evidence about the effectiveness
of this new model of care, and enable ambulance
services to use resources efficiently.
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pathways of care at the index incident. We shall compare National
Health Service (NHS) and patient/carer costs between intervention
and control groups and estimate quality-adjusted life years (QALYs)
gained from the intervention and thus incremental cost per QALY. We
shall estimate wider system effects on key-performance indicators.
We shall interview 60 intervention patients, and conduct focus
groups with contributing NHS staff to explore their experiences of the
assessment and referral service. We shall analyse quantitative trial
data by ‘treatment allocated’; and qualitative data using content
analysis.
Ethics and dissemination: The Research Ethics Committee for
Wales gave ethical approval and each participating centre gave NHS
Research and Development approval. We shall disseminate study
findings through peer-reviewed publications and conference
presentations.
Trial Registration: ISRCTN 60481756
INTRODUCTION
We have written this protocol paper during trial imple-
mentation and include information about study pro-
gress. We have carried out several minor amendments to
the protocol since the original version. We highlight key
differences between the original and current protocol,
including sample-size calculations and consent
processes.
Background
Falls in older people are recognised as an important issue
internationally,1 2 with high human and organisational
costs. Reduction in quality of life and physical activity lead
to social isolation and functional deterioration with a high
risk of resultant dependency and institutionalisation.3–5 In
the UK, falls account for 3% (about £980 million) of total
National Health Service (NHS) expenditure,6 and the pre-
vention of falls in older people has been highlighted as a
priority.7 8
Although prevention appears effective,8 reducing falls
and associated morbidity depends on early identiﬁcation
of people at high risk and delivery of interventions
across traditional service boundaries9, priorities now
reﬂected in national and international guidelines.10–12
A recent systematic review and meta-analysis found
limited evidence of beneﬁt from multifactorial risk
assessment and targeted intervention for falls in
primary, community or emergency care. However, none
of these trials reported quantitative outcome data on
health-related quality of life (HRQoL), and although six
had been undertaken in emergency care, none were
conducted in prehospital care.
Older people taken to emergency departments following
a fall are highly likely to fall again in the following year,
with a 30% chance of sustaining fracture or dislocation.13
Multidisciplinary interventions have increased uptake of
preventative advice,14 15 and reduced subsequent falls,
length of hospital stay and disability.13 Older people com-
monly call an emergency ambulance (999) following a fall.
In London (UK), this group accounts for about 60 000
attendances (8% of emergency ambulance responses)
each year. This is very similar to the proportion reported in
an urban Emergency Medical Service system in the USA.16
Non-conveyance to emergency departments (EDs) is high
in this group—close to 40% in London,17 elsewhere in the
UK,18 19 and the USA.16 Most (90%) falls not conveyed to
ED occur in the home.20 Non-conveyance of patients is
recognised internationally as a safety and litigation risk.21
More widely, in most UK ambulance services, treat-
ment protocols advise conveying patients to ED unless
they refuse to travel to hospital. In practice, however,
ambulance services allow their staff to decide who can
be safely left at home. Little is known about how, in the
absence of speciﬁc protocols or training to leave older
people who fall at home, paramedics make these deci-
sions. A US study acknowledged the pragmatic nature of
negotiation with patients whether to go to hospital or
not.22 A UK study identiﬁed factors affecting these deci-
sions including: experience and conﬁdence of ambu-
lance staff, time into the shift, presence of carers, quality
of the accommodation, waiting times at the local ED
and prior knowledge of the patient.23 There have been
few established referral pathways, or even encourage-
ment to inform patients’ general practitioners (GPs), or
other services of the emergency call. However, recent
policy changes in the UK have encouraged the develop-
ment and implementation of alternative models of care
for delivery by the ambulance service, including
enhanced training for paramedics, and community-
based referral pathways for patients who do not need
the ED.24 25
The National Service Framework for Older People7
advocates that ambulance crews refer older people who
have fallen to community-based care, although this
reﬂects consensus rather than research evidence.
A recent study found that referring elderly patients, who
had fallen and been left at home by their attending
ambulance crew, to a community-based falls-prevention
service reduced further falls and improved clinical out-
comes.26 Previous studies in this setting have found that
change in practice is difﬁcult to achieve and new path-
ways of care are difﬁcult to exploit.27 Furthermore, there
is little evidence about the safety of non-conveyance
decisions by paramedics.28
The SAFER 2 trial has followed the MRC framework
for developing and evaluating complex interventions.29
Logan26 has since reinforced the case for a multicentre
trial of an intervention in which attending ambulance
crews assess patients who have fallen and refer them to
community-based falls services from the scene.30–34
We hypothesise that the intervention works by improving
the decision-making of paramedics to use falls services
to best effect. If so, we expect better outcomes and
reduced costs, both for patients now referred to falls ser-
vices and for those not now taken to ED unnecessarily.
Achieving these improved outcomes for patients requires
participating paramedics to change their practice in
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relation to assessment, conveyance and referral of
patients. Hence, we have designed SAFER 2 to gather
data about each of the elements of the pathway and to
assess both processes and outcomes.
AIM AND OBJECTIVES
Aim
To assess the beneﬁts and costs to patients and the NHS
of a complex intervention comprising education, clinical
protocols and pathways enabling paramedics to assess
older people who have fallen and refer them to
community-based falls services when appropriate.
Objectives
1. To compare outcomes, processes and costs of care
between intervention and control groups.
▸ Patient outcomes: rate and pattern of subse-
quent emergency healthcare contacts or deaths,
for any reason and for falls; HRQoL; psycho-
logical status, especially fear of falling; and
change in place of residence.
▸ Processes of care: pathway of care at index fall;
subsequent healthcare contacts; ambulance
service operational indicators and protocol com-
pliance including clinical documentation.
▸ Costs of care: provided by NHS and personal
social services; incurred by patients or carers in
seeking care.
2. To estimate wider system effects of the introduction
of the intervention on ambulance service perform-
ance and costs.
3. To understand how patients experience the new
health technology.
4. To identify factors which facilitate or hinder the use
of the intervention.
5. To inform the development of methods for falls
research, especially outcome measures recommended
for trials of interventions for older people who fall.2
METHODS AND ANALYSIS
Trial design and management
This is a cluster randomised trial (CRT), with economic
and qualitative components. We have randomly allocated
ambulance stations between trial groups, both to enable
us to support change of practice in the intervention
group and to minimise contamination between groups
in evaluating patient outcomes. The economic compo-
nent addresses Objectives 1 and 2 by valuing the bene-
ﬁts and costs of the intervention.
The qualitative component addresses Objectives 2 and 3
through two methods: semistructured interviews with par-
ticipants (or their carers) attended by intervention para-
medics; and focus groups with intervention paramedics
and NHS service providers.
Following the MRC guidelines for good practice in
clinical trials,35 the management structure comprises
external Trial Steering Committee (TSC) and Data
Monitoring and Ethics Committee (DMEC); and
internal Trial Management Group (TMG), Local
Implementation Team (LIT) in each area, and core
team. The TSC oversees the trial and provides advice to
the Chief Investigator (CI), the Health Technology
Assessment (HTA) Programme and the Sponsor on all
aspects. The DMEC has access to unblinded comparative
data to monitor the data and make recommendations to
the TSC whether there are ethical or safety reasons why
the trial should not continue. The TMG manages the
trial from day to day. The LITs deal with issues emerging
at each trial site and provide opportunities to share pro-
gress. The core team is smaller, including the CI and
research team.
Setting and site selection
We are undertaking the trial in prehospital emergency
care, with paramedics delivering the intervention in
partnership with community-based falls services. We
have selected three ambulance services in England and
Wales, covering a mixture of urban and rural areas
where a falls service was available, but no process in
place for paramedics to make direct referrals from the
scene of 999 attendances.
Participants
We invited paramedics based at ambulance stations that
normally attend patients within the catchment area of
participating falls services, to participate in the trial
before allocating those stations randomly between
groups.
Patients are eligible for the trial if they: are aged
65 years or over; live in the catchment area of participat-
ing falls services; and are attended by a study paramedic
following an emergency call to the ambulance service
which is coded by a dispatcher as a fall without priority
symptoms (Advanced Medical Priority Dispatch System
code 17). We exclude patients attended by an Emergency
Care Practitioner unless their attendance was at the
request of a trial paramedic. We recruit patients to the
trial only once, since subsequent falls constitute patient
outcomes.
Interventions
The core of the health technology that we are evaluating
is a clinical protocol for the care of older people who
have fallen, enabling emergency ambulance paramedics
to assess and refer them to community-based falls ser-
vices. Development of the intervention built on previous
studies in this ﬁeld. This complex intervention com-
prises training, referral pathways to falls services, individ-
ual outcome reports to referring paramedics from falls
services, and clinical and operational support to change
practice including a feedback loop between paramedics
and ambulance service managers. Specialist subgroups
developed speciﬁc components of the intervention for
SAFER 2, while modelling and stakeholder feedback
facilitated testing of economic viability and expected
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affects. Sites agreed common minimum standards for
core elements of the intervention at the outset, while
permitting local differences in processes like referral
and documentation.
In accordance with the National Institute of Clinical
Excellence guidelines for the assessment and prevention
of falls,12 the multidisciplinary falls-services team
includes nursing, physiotherapy, occupational therapy
and rehabilitation provision. They provide risk assess-
ment and treatment including postural stability and
balance training, home hazard advice, equipment and
adaptations, medical review including osteoporosis risk,
advice on fear of falls, social care, beneﬁt advice and
referral to other community services.
Control intervention: we have asked paramedics based
at control stations to continue their usual practice.
Although we know that conveyance rates vary consider-
ably among services, stations and paramedics, we have
not sought standardisation of practice as we do not
know what is best. Current practice in the control group
is therefore care as usual comprising assessment of
injury or other conditions requiring immediate care,
assistance in moving from where they have fallen, and
conveyance to ED unless the patient refuses.
Outcomes
Outcome measures at 1 and 6 months after patients’
index calls are consistent with recommendations of
Prevention of Falls Network Europe (PrOFaNE).36
Principal outcomes
The rate of further contacts with emergency healthcare
providers (999 calls, ED attendances, emergency admis-
sions or death)—both for any cause and speciﬁcally for
falls, as summarised by
▸ Proportion of patients who suffer these events
▸ Interval to ﬁrst event
▸ Event rate
Secondary outcomes
▸ Duration of inpatient episodes
▸ Fractures arising from further falls
▸ Self-reported further falls
▸ Health-related quality of life, as measured by the
SF1237
▸ ‘Fear of falling’ as measured by the modiﬁed falls efﬁ-
cacy scale38
▸ Patient satisfaction as measured by the (quality of
care monitor)39
▸ Change in place of residence
▸ Pathway of care as measured by routine ambulance
service data on proportions conveyed to ED, referred
to falls service, referred to other providers, or left at
scene without further care
▸ Durations of: ambulance service job cycle, episode of
care, time to falls service response
▸ Compliance with guidelines for ambulance service
clinical documentation; referrals; and falls services
follow-up
▸ Costs of care to NHS and personal social services, esti-
mated by routine data from participating services
▸ Self-reported costs incurred by patients and carers
▸ Views of ambulance service paramedics, managers
and partners on implementation of the intervention
▸ Experience and satisfaction of patients receiving the
intervention
Data collection methods
This CRT does not approach participants at the point of
treatment, because they may be in distress and cannot
give informed consent. Instead, we seek retrospective
consent to follow up through routine medical records
and by postal questionnaire. Following experience in
several earlier experimental studies, we originally pro-
posed an ‘opt-out’ procedure, and gained provisional
ethical approval from a Multicentre Research Ethics
Committee. However, information governance approval
for this approach was not forthcoming. We therefore
designed an active consent process, in which we contact
patients to seek consent to follow up ﬁrst by post, and
then if necessary by telephone or home visit, and gained
the necessary approvals. We also include a £5 voucher
with each invitation pack to thank participants for their
time. We are also undertaking anonymised follow-up
through linked records—in Wales, using the Secure
Anonymised Information Linkage (SAIL) databank,40
and in England, using similar centralised records—again
with information governance approval.
Sample size and power
We estimated the sample size for the trial from our prin-
cipal outcome—the proportion of participants who,
within 6 months, die or contact emergency services (999
service or ED). From previous trials of interventions for
older people who have sustained a fall and presented for
emergency treatment, summarised in a recent systematic
review,41 we make the conservative estimate that trial
patients have about 50% chance of making another
emergency contact within 6 months. As the intervention
appears cheap a priori, we judge that a change of 5% in
this proportion may be clinically and economically
important. In the absence of clustering, a sample size of
4190 evaluable participants would yield 90% power to
detect a change of at least 5% (from 50% to ≤45% or
≥55%) when using two-sided 5% signiﬁcance level.
As participants come from 25 clusters (ambulance sta-
tions), we need to adjust this sample size to allow for
intracluster correlation (ICC). We estimate this ICC
from the ﬁndings of the SAFER 1 trial,41 which evalu-
ated the clinical and cost effectiveness of Computerised
Clinical Decision Support software for use by paramedics
when attending older adults who had a fall. SAFER 1
estimated the ICC for the same outcome, but over
1 month rather than 6, as zero when clustering
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participants by station (as in SAFER 2) but 0.005 when
clustering participants by paramedic (as in SAFER 1).42
To be conservative, we allow for an ICC of 0.002. Solving
a simple algebraic equation then yields: a target of 251.6
evaluable participants per station; a variance inﬂation
factor of (1+(251.6–1)×0.002) viz 1.5012; and a total
evaluable sample of 4190×1.5012=6290 viz 25×251.6.
This sample will also have more than 90% power to
detect a change of 0.18 in the estimated mean of 1.8
emergency contacts per participant over 6 months, given
an estimated SD of 1.5. Hence, SAFER 2 can detect a
difference of 1 emergency contact in 10 avoided (or
induced) by the intervention.
We had originally postulated that patients recruited to
the study would have a 40% chance of making an emer-
gency contact within 6 months; and that the ICC could
be as high as 0.03. Under those assumptions, our target
sample of about 6300 would have yielded 80% power to
detect a change of at least 10% (ie, from 40% to ≤30%
or ≥50%) when using a two-sided 5% signiﬁcance level.
When SAFER1 showed that the assumed ICC was unduly
pessimistic, recruitment was progressing well. Rather
than ﬁnish the trial early, we decided with the approval
of both TSC and DMEC to be less conservative in assum-
ing a worst ICC of 0.02, thus yielding enough power to
detect a change of only 5% in the emergency contact
rate, still a clinically important difference in the view of
our advisers.
Early in SAFER 2, approximately 1 in 10 recruited par-
ticipants consented to complete questionnaires, conﬁ-
dential but not anonymised. This has now increased to 1
in 4 for the 1-month questionnaire. The trial is on target
to achieve a sample size of 6290, and the resulting
sample of 800 returned questionnaires at 6 months
would yield 90% power of detecting an effect size of
0.25 (equivalent to one-quarter of the population SD) in
each of the questionnaire outcomes. Such a low
response rate requires that analysis include rigorous non-
response analysis to test whether ﬁndings extrapolate to
the entire population of interest.
Loss to follow-up
We monitor routine outcomes in two forms: anonymised
linked data from central NHS databanks for all patients
that we can match to NHS administrative records, which
needs information governance approvals but no
consent; and identiﬁable data from NHS providers for
patients who consent for us to do this. Our experience
in the recently completed SAFER 1 trial in a similar
population in Wales suggests we can achieve 90%
follow-up through anonymised linked data. Although
this will reduce statistical power below the 90% postu-
lated in our calculations, it will still exceed the trad-
itional 80%.
Randomisation
An independent statistician randomised the 25 partici-
pating ambulance stations between intervention and
control groups after the paramedics had volunteered to
participate, thus minimising selection bias; the stratifying
variables were the receiving falls service and the number
of paramedics participating in each station.
Blinding
Although the trial managers and ﬁeldworkers need to
know the allocation of all participating ambulance sta-
tions for operational reasons, we keep the trial statisti-
cian blind to these allocations.
Statistical analysis
Primary analysis will be by ‘treatment allocated’.
Analyses will include logistic regression for binary out-
comes, cross-tabulations and risk ratios for categorical
outcomes, and survival analysis including Cox’s propor-
tional hazards models for times to events. We shall use
multilevel modelling to estimate (random) station
effects and (ﬁxed) group effects and analyse repeated
observations as such.
Our principal outcomes comprise a hierarchy, and will
undergo analysis incrementally: ﬁrst deaths; second
emergency admissions plus deaths; then ED attendances
plus admissions and deaths and ﬁnally 999 calls plus
attendances, admissions and deaths. Analysis at 1 and
6 months will cover, for all such events, and those coded
as a fall: the proportion of patients that call 999, attend
ED, get admitted or die; survival analysis of the time to
the ﬁrst subsequent emergency contact; the mean
number of further emergency contacts adjusted for time
at risk, excluding days in hospital or after death; and
recurrent event analysis where feasible. As patients’ deci-
sion to call 999 after later events could reﬂect the care
they received at the index call, we shall check whether
these later calls reﬂect valid need rather than health-
seeking behaviour, by comparing them with self-reported
falls and health-related quality of life. We will also
examine the effect of the intervention on patient satisfac-
tion, health-related quality of life and costs (as described
separately, below).
Potential predictors of triage decisions include the dis-
tance between the site of the index event and the ED;
patients’ age, sex and history of previous falls; type of
presentation (eg, out-of-hours); and time since recruit-
ment, as routine data may be less accessible for patients
recruited later in the trial. We shall therefore use these as
covariates in the analysis. It is possible that patients in the
catchment area of one station may receive care for a sub-
sequent event from another station participating in the
study but allocated to a different group. Nevertheless,
analysis will still be by treatment allocated. Secondary
analyses will examine outcomes by treatment received,
namely whether participants got referred to falls services.
To identify any wider system effects, we shall compare
response times during the trial period across the study
catchment area and surrounding areas with pretrial
response times and response times elsewhere. We shall
also compare the characteristics of those included and
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not included through both consented and anonymised
routes, to explore whether there are systematic differ-
ences between groups and routes that may inﬂuence
outcomes.
To inform the development of outcome measures for
falls research as recommended by ProFaNE, we shall
compare SF12 and derived SF6D scores with mFES
scores to establish their construct validity. We shall also
assess their predictive validity by comparing scores with
the number of further events and the time to the ﬁrst
subsequent event.
Economic evaluation
We are undertaking economic evaluation alongside the
CRT from the perspective of the UK NHS and personal
social services, and patients and their families.
Economic analysis will estimate the costs of providing
the intervention, the costs to patients and families, and
the consequences of the scheme for the NHS and social
services in terms of inpatient admissions, ED atten-
dances, GP consultations, out-of-hours GP contacts,
NHS direct contacts, and use of social services. We shall
collect data on participants’ use of health service and
social services resources from paramedic records,
routine hospital records and patient-completed ques-
tionnaires. We shall estimate NHS resource use from
routine data including duration of ambulance job cycles
and episodes of care, records of resource use and
patient records. We shall estimate social services
resource costs from discussion with relevant social ser-
vices departments. We shall calculate the resulting costs
using unit costs from published sources. We shall esti-
mate the quality-adjusted life years (QALYs) gained by
the intervention from the SF6D. We shall derive an
incremental cost-per-QALY and present the resulting
cost-effectiveness plane and associated cost-effectiveness
acceptability curves. We undertake sensitivity analysis to
assess the robustness of the results to changes in the con-
ﬁguration of the scheme and other health-service costs.
We recognise that the follow-up period is not long
enough to yield evaluation over the lifetime of partici-
pants. We shall therefore develop a decision model to
extrapolate costs and effects beyond the data generated
by the trial—probably from the hazard rates estimated
by the trial. We shall construct alternative scenarios from
previous studies and discussions with experts—to judge
the extent to which risks will remain constant or change
over time, and assess the implications of using a longer
time-horizon on the basic analysis of costs and beneﬁts.
Qualitative study
One researcher at each site is undertaking semistruc-
tured interviews with older people who have been
recruited to the study and focus groups interviews with
intervention paramedics and service providers. We are
purposively sampling 20 participants in each site
attended by intervention paramedics following a fall, to
include patients transferred to the ED, patients referred
to the falls service and patients neither transferred or
referred. We interview these participants or their carers
at a site of their choosing 6–8 weeks after their index
fall. We developed the interview schedule to gather
information in depth about the experience of patients
in the intervention group, and we consulted user groups
about the content and acceptability of that schedule. In
particular, we are interested in intervention ﬁdelity and
the perceptions of those who received the intervention
—for instance, whether they feel conﬁdent about para-
medics’ decisions whether they need to go to the ED;
and how they feel about the process of referral.
Focus groups are a useful way of understanding organ-
isational change,43 and exploring the success or failure
of particular programmes.44 At each of the three
centres, we are undertaking focus groups with interven-
tion paramedics before and after the trial period.
Following the trial period, we shall hold focus groups
with a range of ambulance service participants in each
centre, including trainers, operational managers, clinical
team leaders and dispatch staff; and with participants
from other partner services in each centre including
falls services, social services and ED. We include six to
eight participants in each focus group, to facilitate dis-
cussions within manageable groups.45 We base the topic
guides on previous research in this area and consult-
ation with our LITs. Two researchers lead each focus
group, one to facilitate discussion and the other to take
notes that link text to speakers and highlight points of
consensus or disagreement and issues that draw strong
emotional responses such as anger, fear or anxiety.
Systematically comparing and analysing qualitative data
in raw form is challenging.46 So, we shall record and tran-
scribe all interviews and focus groups with the permission
of participants. A protocol will ensure that we use stand-
ard format and conventions throughout the transcription
process. We shall analyse all these data by using NVivo
software to explore commonalities and differences in
topics that emerge from the guides. Two researchers will
analyse all these data independently and then meet to
discuss and agree ﬁnal coding and interpretation.
Adverse event reporting
SAFER 2 is following the principles of the Standard
Operating Procedure for adverse events developed by
the West Wales Organisation for Rigorous Trials in
Health (WWORTH). As the study population has high
mortality and morbidity, we do not routinely record or
report adverse events that are neither serious nor
adverse reactions (ARs) in the sense of possibly being
caused by the new clinical protocol for referring to falls
services. The main potential AR is misdiagnosis, which
could lead to an inappropriate pathway of care. As mis-
diagnosis is reliably identiﬁable only through patient
complaints or coroner’s inquest, we focus on these, and
treat them as serious adverse reactions (SAR). Any
patient complaint or coroner’s inquest at which the
ambulance service is asked to supply information related
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to non-conveyance of a trial participant from the index
incident will trigger investigation by the local principal
investigator and, chief investigator. We also investigate
suspected ARs brought to our attention in any other way.
Death or emergency hospital admission is a serious
adverse event (SAE). As these form the primary
outcome of this trial, and are not unusual or unex-
pected in the study population, we shall report them at
the end of the trial. In particular imbalance between
intervention and control groups in the occurrence of
SAEs or SARs, will be the subject of statistical analysis at
the end of the trial.
ETHICS AND DISSEMINATION
Ethics and R&D governance
Current practice has been shown to carry risks for
patients, as many (up to half) are left at scene without
further care, and many of these (about half) make
further emergency healthcare contacts within 2 weeks.19
Following a recommendation in the National Service
Framework for Older People,9 ambulance services
around the UK have begun to implement alternative
pathways of care for older people who have fallen, either
through emergency care practitioner schemes or direct
referral from paramedics. Research is urgently needed
to understand the safety, costs and clinical effectiveness
of this new model of care. Ethical and consent issues in
CRTs are acknowledged to present their own unique
challenges.47 Against this background, we have obtained
ethical approval from the Research Ethics Committee
for Wales, information governance approval from the
National Information Governance Board, and NHS
R&D approval from each participating Health Board,
NHS Trust and Primary Care Trust.
Service users
We include patients and carers as active participants in
the research at all stages. As the relevant service users
are often frail, we are using innovative methods to facili-
tate their contributions. They attend TSC, DMEC, TMG
and LIT meetings and additional service user groups,
where they contribute to the research process and
discuss issues affecting older people with a history of
falls. We do not expect them to attend full research
team meetings, although they may bring their views to
the team meetings, following meetings with service users
in other forums. Including service users in emergency
care research is a particular challenge,48 but is achiev-
able and brings rewards to the trial and the team.
Dissemination
We shall comply with the CONSORT guidelines.49 We will
present the study results at national and international con-
ferences and publish them in peer-reviewed journals. In
accordance with recommendations, we have registered
SAFER 2 in a public registry (http://www.controlled-trials.
com/isrctn/, Identiﬁer: ISRCTN 60481756).
DISCUSSION
Progress so far (September 2012)
The SAFER 2 trial is underway in three ambulance ser-
vices, in collaboration with eight participating falls ser-
vices and 12 hospitals with EDs. We have recruited 220
paramedics from 25 ambulance stations (clusters) to the
trial. In the ﬁrst year of the trial, we recruited over 4000
patients. Hence, we are on target to detect clinically
important differences in outcomes at 6 months, while
monitoring the safety of the intervention at 1 month.
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